111 related articles for article (PubMed ID: 1664185)
1. AICAriboside inhibits gluconeogenesis in isolated rat hepatocytes.
Vincent MF; Marangos P; Gruber HE; Van den Berghe G
Adv Exp Med Biol; 1991; 309B():359-62. PubMed ID: 1664185
[No Abstract] [Full Text] [Related]
2. Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes.
Vincent MF; Bontemps F; Van den Berghe G
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):267-72. PubMed ID: 1531010
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes.
Vincent MF; Marangos PJ; Gruber HE; Van den Berghe G
Diabetes; 1991 Oct; 40(10):1259-66. PubMed ID: 1657665
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycaemic effect of AICAriboside in mice.
Vincent MF; Erion MD; Gruber HE; Van den Berghe G
Diabetologia; 1996 Oct; 39(10):1148-55. PubMed ID: 8897001
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fructose-1,6-bisphosphatase by aminoimidazole carboxamide ribotide prevents growth of Salmonella enterica purH mutants on glycerol.
Dougherty MJ; Boyd JM; Downs DM
J Biol Chem; 2006 Nov; 281(45):33892-9. PubMed ID: 16987812
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase.
Henin N; Vincent MF; Gruber HE; Van den Berghe G
FASEB J; 1995 Apr; 9(7):541-6. PubMed ID: 7737463
[TBL] [Abstract][Full Text] [Related]
7. Substrate cycling between 5-amino-4-imidazolecarboxamide riboside and its monophosphate in isolated rat hepatocytes.
Vincent MF; Bontemps F; Van den Berghe G
Biochem Pharmacol; 1996 Oct; 52(7):999-1006. PubMed ID: 8831718
[TBL] [Abstract][Full Text] [Related]
8. Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells.
Javaux F; Vincent MF; Wagner DR; van den Berghe G
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):913-9. PubMed ID: 7848293
[TBL] [Abstract][Full Text] [Related]
9. AMPK or ZMPK?
Shakulov RS
Med Hypotheses; 2006; 67(3):670. PubMed ID: 16762515
[No Abstract] [Full Text] [Related]
10. Application of (13)C-filtered (1)H NMR to evaluate drug action on gluconeogenesis and glycogenolysis simultaneously in isolated rat hepatocytes.
Hansen SH; McCormack JG
NMR Biomed; 2002 Aug; 15(5):313-9. PubMed ID: 12203222
[TBL] [Abstract][Full Text] [Related]
11. Z-nucleotides formation in human and rat cells.
Gruber HE; Jimenez R; Barankiewicz J
Adv Exp Med Biol; 1991; 309B():363-6. PubMed ID: 1781398
[No Abstract] [Full Text] [Related]
12. Influence of succinylpurines on the binding of adenosine to a particulate fraction of rat cerebral cortex.
Vincent MF; Van den Berghe G
Adv Exp Med Biol; 1989; 253B():441-5. PubMed ID: 2610130
[No Abstract] [Full Text] [Related]
13. Effect of 5-amino-4-imidazolecarboxamide riboside on renal ammoniagenesis. Study with [15N]aspartate.
Nissim I; Yudkoff M; Segal S
J Biol Chem; 1986 May; 261(14):6509-14. PubMed ID: 2871025
[TBL] [Abstract][Full Text] [Related]
14. Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase.
Hunter RW; Hughey CC; Lantier L; Sundelin EI; Peggie M; Zeqiraj E; Sicheri F; Jessen N; Wasserman DH; Sakamoto K
Nat Med; 2018 Sep; 24(9):1395-1406. PubMed ID: 30150719
[TBL] [Abstract][Full Text] [Related]
15. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle.
Wojtaszewski JF; Jørgensen SB; Hellsten Y; Hardie DG; Richter EA
Diabetes; 2002 Feb; 51(2):284-92. PubMed ID: 11812734
[TBL] [Abstract][Full Text] [Related]
16. [Effect of AICAriboside on the protection of the ischemic myocardium and its mechanism of action].
Shi AY
Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):171-3. PubMed ID: 4012259
[No Abstract] [Full Text] [Related]
17. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
Galiñanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation.
Guigas B; Bertrand L; Taleux N; Foretz M; Wiernsperger N; Vertommen D; Andreelli F; Viollet B; Hue L
Diabetes; 2006 Apr; 55(4):865-74. PubMed ID: 16567505
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminoimidazole-4-carboxamide riboside induces apoptosis in Jurkat cells, but the AMP-activated protein kinase is not involved.
López JM; Santidrián AF; Campàs C; Gil J
Biochem J; 2003 Mar; 370(Pt 3):1027-32. PubMed ID: 12452797
[TBL] [Abstract][Full Text] [Related]
20. Regulation of adenosine concentrations by acadesine (AICA-riboside) in human B-lymphoblasts.
Barankiewicz J; Jimenez R; Uyesaka J; Gruber HE
Adv Exp Med Biol; 1991; 309A():275-8. PubMed ID: 1789225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
